JP2017527274A5 - - Google Patents

Info

Publication number

JP2017527274A5

JP2017527274A5 JP2017504103A JP2017504103A JP2017527274A5 JP 2017527274 A5 JP2017527274 A5 JP 2017527274A5 JP 2017504103 A JP2017504103 A JP 2017504103A JP 2017504103 A JP2017504103 A JP 2017504103A JP 2017527274 A5 JP2017527274 A5 JP 2017527274A5

Authority

JP

Japan

Prior art keywords

binding molecule

seq

sequence

bispecific binding

light chain

Prior art date

2015-07-24

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 claims 31
• 102000004196 processed proteins & peptides Human genes 0.000 claims 20
• 230000004927 fusion Effects 0.000 claims 19
• 229920001184 polypeptide Polymers 0.000 claims 19
• 239000002157 polynucleotide Substances 0.000 claims 16
• 102000040430 polynucleotide Human genes 0.000 claims 16
• 108091033319 polynucleotide Proteins 0.000 claims 16
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 15
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 15
• 239000008194 pharmaceutical composition Substances 0.000 claims 15
• 206010028980 Neoplasm Diseases 0.000 claims 9
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 7
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 7
• 201000011510 cancer Diseases 0.000 claims 7
• 210000001744 T-lymphocyte Anatomy 0.000 claims 6
• 210000004027 cell Anatomy 0.000 claims 5
• 108060003951 Immunoglobulin Proteins 0.000 claims 4
• 102000018358 immunoglobulin Human genes 0.000 claims 4
• 239000000203 mixture Substances 0.000 claims 4
• 238000000034 method Methods 0.000 claims 3
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
• 239000005551 L01XE03 - Erlotinib Substances 0.000 claims 2
• 239000002136 L01XE07 - Lapatinib Substances 0.000 claims 2
• 230000004988 N-glycosylation Effects 0.000 claims 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
• 229960005395 cetuximab Drugs 0.000 claims 2
• 229960001433 erlotinib Drugs 0.000 claims 2
• AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 claims 2
• 239000012634 fragment Substances 0.000 claims 2
• 230000013595 glycosylation Effects 0.000 claims 2
• 238000006206 glycosylation reaction Methods 0.000 claims 2
• 229960004891 lapatinib Drugs 0.000 claims 2
• BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 102000005962 receptors Human genes 0.000 claims 2
• 108020003175 receptors Proteins 0.000 claims 2
• 150000003384 small molecules Chemical class 0.000 claims 2
• 229960000575 trastuzumab Drugs 0.000 claims 2
• 206010006187 Breast cancer Diseases 0.000 claims 1
• 208000026310 Breast neoplasm Diseases 0.000 claims 1
• 201000009030 Carcinoma Diseases 0.000 claims 1
• 206010008342 Cervix carcinoma Diseases 0.000 claims 1
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
• 208000006168 Ewing Sarcoma Diseases 0.000 claims 1
• 201000010915 Glioblastoma multiforme Diseases 0.000 claims 1
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims 1
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims 1
• ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 1
• 206010029260 Neuroblastoma Diseases 0.000 claims 1
• 206010033128 Ovarian cancer Diseases 0.000 claims 1
• 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
• 229930012538 Paclitaxel Natural products 0.000 claims 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
• 206010060862 Prostate cancer Diseases 0.000 claims 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
• 208000004337 Salivary Gland Neoplasms Diseases 0.000 claims 1
• 206010061934 Salivary gland cancer Diseases 0.000 claims 1
• 206010039491 Sarcoma Diseases 0.000 claims 1
• 208000021712 Soft tissue sarcoma Diseases 0.000 claims 1
• 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 claims 1
• 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
• 208000009956 adenocarcinoma Diseases 0.000 claims 1
• 150000001413 amino acids Chemical class 0.000 claims 1
• 190000008236 carboplatin Chemical compound 0.000 claims 1
• 229960004562 carboplatin Drugs 0.000 claims 1
• 230000001413 cellular effect Effects 0.000 claims 1
• 201000010881 cervical cancer Diseases 0.000 claims 1
• 239000003795 chemical substances by application Substances 0.000 claims 1
• 229960004397 cyclophosphamide Drugs 0.000 claims 1
• 229960003668 docetaxel Drugs 0.000 claims 1
• 229960004679 doxorubicin Drugs 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• 230000003352 fibrogenic effect Effects 0.000 claims 1
• 206010017758 gastric cancer Diseases 0.000 claims 1
• 230000002496 gastric effect Effects 0.000 claims 1
• 201000007492 gastroesophageal junction adenocarcinoma Diseases 0.000 claims 1
• 208000005017 glioblastoma Diseases 0.000 claims 1
• 201000000459 head and neck squamous cell carcinoma Diseases 0.000 claims 1
• 238000007912 intraperitoneal administration Methods 0.000 claims 1
• 238000007913 intrathecal administration Methods 0.000 claims 1
• 238000001990 intravenous administration Methods 0.000 claims 1
• 238000007914 intraventricular administration Methods 0.000 claims 1
• 208000032839 leukemia Diseases 0.000 claims 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
• 201000001441 melanoma Diseases 0.000 claims 1
• 206010061289 metastatic neoplasm Diseases 0.000 claims 1
• 239000002773 nucleotide Substances 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 claims 1
• 201000008968 osteosarcoma Diseases 0.000 claims 1
• 229960001592 paclitaxel Drugs 0.000 claims 1
• 201000002528 pancreatic cancer Diseases 0.000 claims 1
• 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
• 201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
• 201000011549 stomach cancer Diseases 0.000 claims 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
• 230000001225 therapeutic effect Effects 0.000 claims 1
• 210000001519 tissue Anatomy 0.000 claims 1